PubRank

Alan Solomon

Author PubWeight™ 48.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005 5.64
2 Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci U S A 2002 2.01
3 Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int 2010 1.83
4 Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood 2010 1.76
5 Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies. Am J Clin Pathol 2008 1.54
6 Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 2005 1.21
7 Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series. Am J Kidney Dis 2010 1.21
8 Micro-imaging of amyloid in mice. Methods Enzymol 2006 1.19
9 Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis. Amyloid 2005 1.13
10 Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins. J Mol Recognit 2004 1.09
11 Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms. Mol Med 2008 1.09
12 Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol 2006 1.09
13 Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice. Comp Med 2008 1.08
14 Elicitation of allergic asthma by immunoglobulin free light chains. Proc Natl Acad Sci U S A 2005 1.03
15 Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 2003 1.00
16 Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628. Blood 2004 0.99
17 Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera. J Immunol 2006 0.98
18 Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains. Biochemistry 2007 0.98
19 Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. J Nucl Med 2006 0.97
20 Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies. Biochemistry 2008 0.96
21 A molecular basis for nonsecretory myeloma. Blood 2004 0.96
22 Two different types of amyloid deposits--apolipoprotein A-IV and transthyretin--in a patient with systemic amyloidosis. Lab Invest 2004 0.95
23 Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro. Am J Kidney Dis 2004 0.94
24 Odontogenic ameloblast-associated protein nature of the amyloid found in calcifying epithelial odontogenic tumors and unerupted tooth follicles. Amyloid 2008 0.93
25 Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains. Proteins 2008 0.92
26 Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope. Biochemistry 2007 0.91
27 Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review. J Peripher Nerv Syst 2006 0.90
28 Unreliability of immunohistochemistry for typing amyloid deposits. Arch Pathol Lab Med 2008 0.89
29 Anti-amyloidogenic activity of IgGs contained in normal plasma. J Clin Immunol 2010 0.88
30 Senile seminal vesicle amyloid is derived from semenogelin I. J Lab Clin Med 2005 0.87
31 Inherent anti-amyloidogenic activity of human immunoglobulin gamma heavy chains. J Biol Chem 2009 0.84
32 Inhibition of pathologic immunoglobulin-free light chain production by small interfering RNA molecules. Exp Hematol 2010 0.84
33 A father and his son with systemic AL amyloidosis. Haematologica 2009 0.84
34 A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding. Amyloid 2003 0.82
35 Odontogenic ameloblast associated protein as a novel biomarker for human breast cancer. Am Surg 2009 0.81
36 Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro. Amyloid 2003 0.81
37 ODAM Expression Inhibits Human Breast Cancer Tumorigenesis. Breast Cancer (Auckl) 2011 0.81
38 AA amyloidosis associated with a mutated serum amyloid A4 protein. Amyloid 2009 0.80
39 Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling. BMC Cancer 2013 0.80
40 Development and evaluation of agents for targeting visceral amyloid. Tijdschr Nucl Geneeskd 2011 0.80
41 Hereditary amyloidosis. N Engl J Med 2002 0.79
42 Human anti-Aβ IgGs target conformational epitopes on synthetic dimer assemblies and the AD brain-derived peptide. PLoS One 2012 0.77
43 Generation and characterization of anti-AA amyloid-specific monoclonal antibodies. Front Immunol 2011 0.76
44 Chemical typing of porcine systemic amyloid as AA-amyloid. Amyloid 2005 0.76
45 Misclassification of amyloidosis is unwarranted. Blood 2006 0.75